Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity-Reference-Cited by-同舟云学术

Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity

Published:2020-08-19 Issue:42 Volume:30 Page:2002131
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Li Chenwen¹²,Dou Yin²,Chen Yidan²,Qi Yuantong²,Li Lanlan²,Han Songling²,Jin Taotao²,Guo Jiawei²,Chen Jianhong¹,Zhang Jianxiang²³^ORCID

Affiliation:

1. Department of Pharmacy Research Institute of Surgery Daping Hospital Third Military Medical University (Army Medical University) Chongqing 400042 China

2. Department of Pharmaceutics College of Pharmacy Third Military Medical University (Army Medical University) Chongqing 400038 China

3. State Key Lab of Trauma, Burn and Combined Injury Institute of Combined Injury Third Military Medical University (Army Medical University) Chongqing 400038 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202002131

Reference85 articles.

1. Atherosclerosis

2. Inflammation, Atherosclerosis, and Coronary Artery Disease

3. Atherosclerosis